Literature DB >> 22747555

Atypical clinical presentations of the A3243G mutation, usually associated with MELAS.

S Blum1, T Robertson, S Klingberg, R D Henderson, P McCombe.   

Abstract

Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a clinical syndrome associated with mitochondrial abnormalities. In approximately 80% of patients, the syndrome is associated with the A3243G mutation. However, it has been realized that the A3243G mutation is not uncommon in the general population and is found in many patients with clinical presentations other than MELAS. We present four patients who presented with rhabdomyolysis, muscle fatigue, external ophthalmoplegia and myoclonic jerks respectively. These patients were all found to have the A3243G mutation on muscle biopsy. These patients illustrate the variety of presentations associated with A3243G mutation.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2011        PMID: 22747555     DOI: 10.1111/j.1445-5994.2010.02379.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

1.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

2.  Fatigue and Exercise Intolerance as Initial Manifestations of a Nonsyndromic Mitochondrial Disorder Due to the Variant m.3243A>G.

Authors:  Josef Finsterer; Sinda Zarrouk
Journal:  Case Rep Neurol Med       Date:  2022-03-23

Review 3.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

4.  Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.

Authors:  Caterina Garone; Aaron R D'Souza; Cristina Dallabona; Tiziana Lodi; Pedro Rebelo-Guiomar; Joanna Rorbach; Maria Alice Donati; Elena Procopio; Martino Montomoli; Renzo Guerrini; Massimo Zeviani; Sarah E Calvo; Vamsi K Mootha; Salvatore DiMauro; Ileana Ferrero; Michal Minczuk
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.